C12N 2750/14221
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2750/14221 (Viruses as such) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 5
- Assignees
- 5
- Inventors
- 15
- Latest grant
- 8 Feb 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Erythroparvovirus with a modified capsid for gene therapy25 Sep 2025US 2025/0295810 A1Synteny Therapeutics, Inc.
- Novel erythroparvovirus associated with respiratory distress in equine26 Oct 2023US 2023/0340032 A1Intervet Inc.
- A method to homogenize parvovirus b19 in clinical samples22 Apr 2021US 2021/0115523 A1Grifols Diagnostic Solutions Inc.
- Methods, nucleic acids, and kits for detection of parvovirus b1917 Apr 2014US 2014/0106337 A1Grifols Therapeutics Inc.
- Human erythrovirus5 Aug 2010US 2010/0196875 A1Talecris Biotherapeutics, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.